Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study

References

• Kosten TR, O’Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348:1786–95. doi:10.1056/NEJMra020617.
   PubMed Web of Science ®Google Scholar
• Hammond CJ, MJ N, Drew S, Arias AJ. Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders. CNS Drugs. 2015;29:293–311. doi:10.1007/s40263-015-0240-4. Cited in PubMed; PMID: 25895020.
   PubMed Web of Science ®Google Scholar
• Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, Randall CL. A double‐blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcoholism. 2009;33:1582–88. doi:10.1111/j.1530-0277.2009.00986.x. Cited in PubMed; PMID: 19485969.
   Google Scholar
• Mayo-Smith MF. Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline. Jama. 1997;278:144–51. doi:10.1001/jama.1997.03550020076042. Cited in PubMed; PMID: 9214531.
   PubMed Web of Science ®Google Scholar
• Leung JG, Hall-Flavin D, Nelson S, Schmidt KA, Schak KM. The role of gabapentin in the management of alcohol withdrawal and dependence. Ann Pharmacother. 2015;49:897–906. doi:10.1177/1060028015585849. Cited in PubMed; PMID: 25969570.
   PubMed Web of Science ®Google Scholar
• Bisaga A, Evans SM. The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend. 2006;83:25–32. doi:10.1016/j.drugalcdep.2005.10.008. Cited in PubMed; PMID: 16298087.
   PubMed Web of Science ®Google Scholar
• Saitz R, Mayo-Smith MF, Roberts MS, Redmond HA, Bernard DR, Calkins DR. Individualized treatment for alcohol withdrawal: a randomized double-blind controlled trial. Jama. 1994;272:519–23. doi:10.1001/jama.1994.03520070039035. Cited in PubMed; PMID: 8046805.
   PubMed Web of Science ®Google Scholar
• Malcolm R, Myrick H, Roberts J, Wang W, Anton R, Ballenger J. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med. 2002;17:349–55. doi:10.1046/j.1525-1497.2002.10201.x. Cited in PubMed; PMID: 12047731.
   PubMed Web of Science ®Google Scholar
• Maldonado JR. Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes–beyond benzodiazepines. Crit Care Clin. 2017;33:559–99. doi:10.1093/alcalc/agv043. Cited in PubMed; PMID: 28601135.
   PubMed Web of Science ®Google Scholar
• Magnus L. Nonepileptic uses of gabapentin. Epilepsia. 1999;40. doi:10.1111/j.1528-1157.1999.tb00936.x. Cited in PubMed; PMID: 10530686.
   PubMed Web of Science ®Google Scholar
• JT S, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA‐Ar). Addiction. 1989;84:1353–57. doi:10.1111/j.1360-0443.1989.tb00737.x. Cited in PubMed; PMID: 2597811.
   Web of Science ®Google Scholar
• JB D, Gache P, Landry U, Sekera E, Schweizer V, Gloor S, Yersin B. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med. 2002;162:1117–21. doi:10.1080/02791072.1994.10472601. Cited in PubMed; PMID: 7913129.
   PubMedGoogle Scholar
• Wiehl WO, Hayner G, Galloway G. Haight ashbury free clinics’ drug detoxification protocols—part 4: alcohol. J Psychoactive Drugs. 1994;26:57–59. doi:10.1080/02791072.1994.10472601. Cited in PubMed: PMID: 7913129.
   PubMed Web of Science ®Google Scholar
• Mariani JJ, Rosenthal RN, Tross S, Singh P, Anand OP. A randomized, open‐label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict. 2006;15:76–84. doi:10.1080/10550490500419110. Cited in PubMed; PMID: 16449096.
   PubMed Web of Science ®Google Scholar
• Bonnet U, Hamzavi-Abedi R, Specka M, Wiltfang J, Lieb B, Scherbaum N. An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol. Alcohol Alcohol. 2009;45:143–45. doi:10.1093/alcalc/agp085. Cited in PubMed; PMID: 20019070.
   PubMed Web of Science ®Google Scholar
• Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology (Cambridge, Mass.). 2009;20:488. doi:10.1097/EDE.0b013e3181a819a1. Cited in PubMed: PMID: 19525685.
   PubMed Web of Science ®Google Scholar
• Parke-Davis & Co.. Neurontin [package insert]. P. Inc., Editor, New York; 2009. https://www.pfizermedicalinformation.com/en-us/neurontin.
   Google Scholar
• Gidal BE, DeCerce J, Bockbrader HN, Gonzalez J, Kruger S, Pitterle ME, Rutecki P, Ramsay RE. Gabapentin bioavailability: effect of dose and frequency of administration in adult patients with epilepsy. Epilepsy research. 1998;31:91–99. doi:10.1016/S0920-1211(98)00020-5. Cited in PubMed: PMID 9714500.
   Google Scholar
• Vadiei N, Smith TL, Walton AE, Kjome KL. 2019. Impact of gabapentin adjunct use with benzodiazepines for the treatment of alcohol withdrawal in a psychiatric Hospital. Psychopharmacol Bull. 49:17–27. Cited in PubMed: PMID 30858636.
   PubMedGoogle Scholar
• Nichols TA, Robert S, Taber DJ, Cluver J. Alcohol withdrawal-related outcomes associated with gabapentin use in an inpatient psychiatric facility. Mental Health Clin. 2019;9:1–5. doi:10.9740/mhc.2019.01.001.
   PubMedGoogle Scholar
• Knight E, Lappalainen L. 2017. Clinical institute withdrawal assessment for alcohol–revised might be an unreliable tool in the management of alcohol withdrawal. Can Fam Physician. 63:691–95. PMID: 28904034.
   PubMed Web of Science ®Google Scholar
• Sachdeva A, Choudhary M, Chandra M. Alcohol withdrawal syndrome: benzodiazepines and beyond. J Clin Diagn Res. 2015;9:VE01. doi:10.7860/JCDR/2015/13407.6538. PMID: 26500991.
   Web of Science ®Google Scholar